INCREDB ID : 409
Home >> Investigator Page Previous      Next
Partha Sarathi Basu, D.G.O., M.D., D.N.B.
Head 
 
Chittaranjan National Cancer Institute
Department of Gynecologic Oncology
Officer in Charge, Preventive Oncology Division
Kolkata - 700 026   
West Bengal   
 
E-mail: basupartha@hotmail.com
Mobile: +91-933-1034-069
Fax: : +91-33-248-51558
 
URL: http://sdcancerlink.com/partha.html
 
Positions Held:
Position Affiliation Time Period
Officer-in-Charge Preventive Oncology, Chittaranjan National Cancer Institute, Kolkata Present
Head Department of Gynecological Oncology, Chittaranjan National Cancer Institute, Kolkata Present
Chief Cervical Cancer Prevention & Control Initiative, Chittaranjan National Cancer Institute, Kolkata Present
Clinical Instructor Population Based Cancer Registry, Kolkata under National Cancer Registry Program (ICMR) Present
Clinical Assistant Hammersmith Hospital, London, UK 1997-1998
Specialist Chittaranjan National Cancer Institute, Kolkata, India 1996-1997
Resident Surgeon Chittaranjan National Cancer Institute, Kolkata, India 1994-1996
Medical Officer R. K. Sarada Mission Matribhavan, Kolkata 1994-1994
 
Area of Specialization:
Gynaecology
Oncology
Publications:
1.
Prevalence of Human Papillomavirus in Women without Cervical Cancer: A Population-based Study in Eastern India. Int J Gynecol Pathol 2011 (In press).     
2. Mitra, S., Mazumder, I., Bhattacharya, N., Singh, R. K., Basu, P. S., Mondal, R. K., Roy, A., Zabarovsky, E. R., Roychoudhury, S. and Panda, C. K.  RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance. Genes, Chromosomes & Cancer. 2010.  49, 155-170. [PubMed]
3. Mitra, S., Mazumder, I., Basu, P. S., Mondal, R. K., Roy, A., Roychoudhury, S. and Panda, C. K.  Amplification of CyclinL1 in uterine cervical carcinoma has prognostic implications. Molecular Carcinogenesis. 2010.  49, 935-943. [PubMed]
4. Chow, S. N., Soon, R., Park, J. S., Pancharoen, C., Qiao, Y. L., Basu, P. and Ngan, H. Y.  Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine. 2010.  28, 3809-3817. [PubMed]
5. Sankaranarayanan, R., Thara, S., Esmy, P. O. and Basu, P.  Cervical cancer: screening and therapeutic perspectives. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. 2008.  17, 351-364. [PubMed]
6. Arbyn, M., Sankaranarayanan, R., Muwonge, R., Keita, N., Dolo, A., Mbalawa, C. G., Nouhou, H., Sakande, B., Wesley, R., Somanathan, T., Sharma, A., Shastri, S. and Basu, P.  Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. International Journal of Cancer. Journal International Du Cancer. 2008.  123, 153-160. [PubMed]
7. Singh, R. K., Indra, D., Mitra, S., Mondal, R. K., Basu, P. S., Roy, A., Roychowdhury, S. and Panda, C. K.  Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene. Human Genetics. 2007.  122, 71-81. [PubMed]
8. Sankaranarayanan, R., Thara, S., Sharma, A., Roy, C., Shastri, S., Mahe, C., Muwonge, R. and Fontaniere, B.  Accuracy of conventional cytology: results from a multicentre screening study in India. Journal of Medical Screening. 2004.  11, 77-84. [PubMed]
9. Sankaranarayanan, R., Shastri, S. S., Basu, P., Mahe, C., Mandal, R., Amin, G., Roy, C., Muwonge, R., Goswami, S., Das, P., Chinoy, R., Frappart, L., Patil, S., Choudhury, D., Mukherjee, T. and Dinshaw, K.  The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detection and Prevention. 2004.  28, 345-351. [PubMed]
11. Sankaranarayanan, R., Chatterji, R., Shastri, S. S., Wesley, R. S., Basu, P., Mahe, C., Muwonge, R., Seigneurin, D., Somanathan, T., Roy, C., Kelkar, R., Chinoy, R., Dinshaw, K., Mandal, R., Amin, G., Goswami, S., Pal, S., Patil, S., Dhakad, N., Frappart, L. and Fontaniere, B.  Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. International Journal of Cancer. Journal International Du Cancer. 2004.  112, 341-347. [PubMed]
12. Basu, P. S., Sankaranarayanan, R., Mandal, R., Roy, C., Das, P., Choudhury, D., Bhattacharya, D., Chatterjee, R., Dutta, K., Barik, S., Tsu, V., Chakrabarti, R. N. and Siddiqi, M.  Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. International Journal of Gynecological Cancer. 2003.  13, 626-632. [PubMed]
13. Ghim, S. J., Basu, P. S. and Jenson, A.  Cervical Cancer: Etiology, Pathogenesis, Treatment, and Future Vaccines. Asian Pacific Journal of Cancer Prevention : APJCP. 2002.  3, 207-214. [PubMed]
14. Ganguly, C., Dutta, K., Sanyal, U., Roy, C., Basu, P. S. and Das, S.  Response of Cervical Intra-epithelial Lesions to Vitamin E Supplementation - A Preliminary Report. Asian Pacific Journal of Cancer Prevention : APJCP. 2001.  2, 305-308. [PubMed]
15. Basu, P. S., D'Arcy, T., McIndoe, A. and Soutter, W. P.  Is needle diathermy excision of the transformation zone a better treatment for cervical intraepithelial neoplasia than large loop excision? Lancet. 1999.  353, 1852-1853. [PubMed]

 

16. Basu, P., Chandna, P., Bamezai, R. N., Siddiqi, M., Saranath, D., Lear, A. and Ratnam, S.  MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer. Journal of Clinical Microbiology. 2011.  49, 3537-3544. [PubMed]
17. Roy, S., Goswami, S., Bose, A., Goswami, K. K., Sarkar, K., Chakraborty, K., Chakraborty, T., Pal, S., Haldar, A., Basu, P., Biswas, J. and Baral, R.  Defective dendritic cell generation from monocytes is a potential reason for poor therapeutic efficacy of interferon alpha2b (IFNalpha2b) in cervical cancer. Translational Research. 2011.  158, 200-213. [PubMed]
18. Basu, P. and Mittal, S.  Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India. The Journal of Obstetrics and Gynaecology Research. 2011.  37, 393-401. [PubMed]
19. Roy, S., Goswami, S., Bose, A., Chakraborty, K., Pal, S., Haldar, A., Basu, P., Biswas, J. and Baral, R.  Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer. Clinical and Vaccine Immunology : CVI. 2011.  18, 571-579. [PubMed]
20. Basu, P., Nessa, A., Majid, M., Rahman, J. N. and Ahmed, T.  Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines. The Journal of Family Planning and Reproductive Health Care. 2010.  36, 131-134. [PubMed]
21. Bhatla, N., Suri, V., Basu, P., Shastri, S., Datta, S. K., Bi, D., Descamps, D. J. and Bock, H. L.  Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women. The Journal of Obstetrics and Gynaecology Research. 2010.  36, 123-132. [PubMed]
22. Basu, P. and Chowdhury, D.  Cervical cancer screening & HPV vaccination: a comprehensive approach to cervical cancer control. The Indian Journal of Medical Research. 2009.  130, 241-246. [PubMed]
23. Basu, P., Ngan, H. Y. and Hseon, T. E.  HPV vaccination in women over 25 years of age: Asian Cervical Cancer Prevention Advisory Board recommendations. The Journal of Obstetrics and Gynaecology Research. 2009.  35, 712-716. [PubMed]
24. Basu, P., Roychowdhury, S., Bafna, U. D., Chaudhury, S., Kothari, S., Sekhon, R., Saranath, D., Biswas, S., Gronn, P., Silva, I., Siddiqi, M. and Ratnam, S.  Human papillomavirus genotype distribution in cervical cancer in India: results from a multi-center study. Asian Pacific Journal of Cancer Prevention : APJCP. 2009.  10, 27-34. [PubMed]
25. Basu, P., De, P., Mandal, S., Ray, K. and Biswas, J.  Study of 'patterns of care' of ovarian cancer patients in a specialized cancer institute in Kolkata, eastern India. Indian Journal of Cancer. 2009.  46, 28-33. [PubMed]
26. Basu, P., Ghoshal, M., Chattopadhyay, K., Mittal, S., Das, P., Choudhury, D. and Chattopadhyay, U.  Cervical screening by visual inspection with acetic acid (VIA) is well accepted by women--results from a community-based study in rural India. Asian Pacific Journal of Cancer Prevention : APJCP. 2006.  7, 604-608. [PubMed]
27. Basu, P., Sarkar, S., Mukherjee, S., Ghoshal, M., Mittal, S., Biswas, S., Mandal, R. and Sankaranarayanan, R.  Women's perceptions and social barriers determine compliance to cervical screening: results from a population based study in India. Cancer Detection and Prevention. 2006.  30, 369-374. [PubMed]
28. Basu, P., Biswas, J., Mandal, R. and Choudhury, P.  Is interferon-alpha and retinoic acid combination along with radiation superior to chemo-radiation in the treatment of advanced carcinoma of cervix? Indian Journal of Cancer. 2006.  43, 54-59. [PubMed]
29.
Palliative Care – An Integral Part of Cancer Management. Indian Journal of Gynecological Oncology. 2006; 4. 5-13. (First author)
 
30. Host Immune Response to Human Papilloma Virus (HPV) as Predictive Marker for Persistence or Progression of Cervical Neoplasia. Indian Journal of Medical Research. 2005. (First author)
31. Sankaranarayanan, R., Basu, P., Wesley, R. S., Mahe, C., Keita, N., Mbalawa, C. C., Sharma, R., Dolo, A., Shastri, S. S., Nacoulma, M., Nayama, M., Somanathan, T., Lucas, E., Muwonge, R., Frappart, L. and Parkin, D. M.  Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. International Journal of Cancer. 2004.  110, 907-913. [PubMed]
32. Sankaranarayanan, R., Nene, B. M., Dinshaw, K., Rajkumar, R., Shastri, S., Wesley, R., Basu, P., Sharma, R., Thara, S., Budukh, A. and Parkin, D. M.  Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica De Mexico. 2003.  45 Suppl 3, S399-407. [PubMed]
33. Grand challenges in global health and the practical prevention program? Asian focus on cancer prevention in females of the developing world. Asian Pacific Journal for Cancer Prevention, 2003; 4. 153-65.
34. Basu, P., Sankaranarayanan, R., Mandal, R., Roy, C., Das, P., Choudhury, D., Datta, K., Karamakar, S., Tsu, V., Chakrabarti, R. N. and Siddiqi, M.  Evaluation of downstaging in the detection of cervical neoplasia in Kolkata, India. International Journal of Cancer.. 2002.  100, 92-96. [PubMed]
35. Retroperitoneal radical hysterectomy. A letter to the Editor. Gynecologic Oncology., 1996. 62. 320-321. (First author)
36. Lithopaedion removed after 18 years. J. Obstet. Gynecol. India., 1993. 43. 448-449. (First author)
38. Forgotten obstetric arts in modern era. J. Obstet. Gynaecol. India., 1992. 42. 469-473. (First author)
39. Muwonge,R., Walter, S. D., Wesley R. S., Basu P., Surendra S Shastri S. S., Thara S., Mbalawa C. G., and Sankaranarayanan, R. Assessing the gain in diagnostic performance when two visual inspection methods are combined for cervical cancer prevention. Cervical Cancer Prevention. 2007. 14, 3. 144-50.

 

Book Chapters:
HPV Vaccines: Need, Feasibility & Recommendations in India. In FOGSI Focus – Cervical Cancer Prevention, Detection & Management. Eds: Konar, H. & Basu, P. 2008. Federation of Obstetrics & Gynecological Societies of India. Mumbai.
Management of abnormal Pap smear; an evidence based guideline. Current Obstetrics & Gynecology. Mukherjee, G. 1st Edition 2006. Jaypee Brothers. New Delhi.
A Practical Approach to Gynecologic Oncology. Basu, P., Singh, A., Pandey, A. 1st Edition, 2005. Jaypee Brothers. New Delhi.
Guidelines for Cervical Cancer Screening Program. National Cancer Control Program. Government of India-WHO Collaborative Program. 2005.
Manuals for Training in Cancer Control. National Cancer Control Program. Directorate General of Health Services, Ministry of Health. November, 2005.
HPV Vaccines: Need, Feasibility & Recommendations in India. In FOGSI Focus – Cervical Cancer Prevention, Detection & Management. Eds: Konar, H. & Basu, P. 2008. Federation of Obstetrics & Gynecological Societies of India. Mumbai.
Management of abnormal Pap smear; an evidence based guideline. Current Obstetrics & Gynecology. Mukherjee, G. 1st Edition 2006. Jaypee Brothers. New Delhi.
A Practical Approach to Gynecologic Oncology. Basu, P., Singh, A., Pandey, A. 1st Edition, 2005. Jaypee Brothers. New Delhi.
Guidelines for Cervical Cancer Screening Program. National Cancer Control Program. Government of India-WHO Collaborative Program. 2005.
Manuals for Training in Cancer Control. National Cancer Control Program. Directorate General of Health Services, Ministry of Health. November, 2005.
Cervical Cancer Control, published by WHO, Geneva. 2000.
 
Grant Support:
Project Title Role Funding Agency Sanction Number Sanction Date
A phase IV, observer-blind, randomized, controlled, multicentric study to assess the safety and immunogenecity of GSK Biologicals HPV-16/18 L1 VLP AS04 vaccine (Cervarix®) administered intramuscularly according to a three-dose schedule (Day 0, Week 6, Month 6) in human immunodeficiency virus-infected (HIV+) female subjects aged 15-25 years, as compared to Merck’s HPV-6/11/16/18 vaccine Principal Investigator
A Randomized, Active Therapy Controlled Phase 2 Study to Assess the Safety and Efficacy of ADXS11-001 with and without Cisplatin as 2nd Line Therapy for the Treatment of Recurrent Cervix Cancer Principal Investigator
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Weekly Farletuzumab (MORAb-003) in Combination with Carboplatin and Taxane in Subjects with Platinum-sensitive Ovarian Cancer in First Relapse Principal Investigator
Investigations on the clearance of human papillomavirus infection in uterine cervix by BASANT, a polyherbal vaginal cream and CURCUMIN Co-PI Department of Biotechnology, Government of India
A two-arm, randomized clinical trial to evaluate concomitant immunotherapy (with Interferon-alpha and Retinoic acid) and radiation therapy for the treatment of advanced cervical cancer in India Principal Investigator

 

 
My CV:   Download
 
Education 
::
M.B.B.S. in Medicine, Medical College Calcutta, Calcutta University, India, 1982-1988
::
D.G.O. in Obstetrics and Gynaecology, Medical College Calcutta, Calcutta University, India, 1990-1991
::
M.D. in Obstetrics and Gynaecology , 1991-1993
::
D.N.B. in Obstetrics and Gynaecology
Honors and Awards
::
2008, Bharat Jyoti Award awarded by India International Friendship Society
::
2006 and 2008, UICC Travel Grant to attend World Cancer Congress
::
2003, Yamagiwa-Yoshida Memorial International Cancer Study Fellowship awarded by International Union Against Cancer (UICC) to pursue research work in cancer immunology at Graham Brown Cancer Center, Louisville, Kentucky
::
1997, Commonwealth Scholarships awarded by Commonwealth University, UK to pursue one year fellowship in Gynaecological Oncology
::
University Honours in Surgery in MBBS examination, Calcutta University
::
Second position in Surgery in Calcutta University in MBBS examination
Member
::
Cancer Prevention & Early Detection Group, National Task Force for formulating strategies for the National Cancer Control Program during 11th five year plan, Ministry of Health & Family Welfare, Government of India
::
Expert Committee on implementation strategies of Cervical Cancer Control Program in India, Ministry of Health & WHO, India
::
MSD Vaccines National Advisory Board
::
Asian Cervical Cancer Prevention Advisory Board
::
Scientific Advisory Committee, Institute of Cytology & Preventive Oncology, New Delhi
::
Member, Project Review Committee, Indian Council for Medical Research, New Delhi
::
Member, Indian Council for Medical Research Subcommittee on Cervical Cancer Control
::
Convener, Oncology Committee, Federation of Obstetrics & Gynecological Societies of India
::
Vice President, Association of Gynecological Oncologists of India
::
Member of Expert Group in preparing a strategy paper on cancer by Department of Biotechnology, Ministry of Science & Technology
::
Course Director & Faculty of several training courses organized by International Agency for Research on Cancer, France
::
Visiting Professor, James Graham Brown Cancer Center, University of Louisville, Kentucky, US
::
Member, Materials Quality Assessment Board, Alliance for Cervical Cancer Prevention, Seattle, USA
::
Nodal Officer, Modified District Cancer Control Program, CNCI, a project under National Cancer Control Program
::
Examiner for PhD Degree examination, Utkal University
::
Member, Asian Cervical Cancer Prevention Advisory Board
::
President, Asia Oceania Research Organization in Genital Infection & Neoplasia
Type of Neoplasms
Female genital system
Ovaries, Uterus, Cervix
Male genital system
Prostate
  Last modified on : Dec 9, 2015
India Cancer Research Database has been developed by the Institute of Bioinformatics with funding from the Department of Biotechnology, Government of India.